DNM1L and lung carcinoma: Drp1 inhibition also sensitised malignant melanoma, lung cancer and osteosarcoma cells to tumour necrosis factor–related apoptosis-inducing ligand (TRAIL)–mediated apoptosis through a caspase-dependent pathway [88].